Please enable JavaScript.
Coggle requires JavaScript to display documents.
ESAD PIPELINE (ARBACLOFEN PLACARBIL (Subpopulation of Alcohol Liver…
ESAD PIPELINE
ARBACLOFEN PLACARBIL
Subpopulation of Alcohol Liver Disease + Cirrhosis (ALD+C) approach based on unmet needs and potential orphan drug status.
Agreement to proceed with the manufacture of Clinical Trial Supplies to support an alcohol interaction study in Alcohol Use Disorder (AUD) and an absorption study in ALD+C. These two studies would enable a clear decision point as to whether both, one, or neither development pathways are viable
-
-
APV202701A
Finalize Target Validation of APV202701A (collaboration with Dr. Mike Nader, North Carolina)
Initiate IND preparedness with Aptuit (INDiGO)